Patent details

EP4031109 Title: EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORS

Basic Information

Publication number:
EP4031109
PCT Application Number:
US2020051341
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP207817180
PCT Publication Number:
WO2021055651
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
EXTENDED RELEASE DOSAGE FORMS FOR TYK2 INHIBITORS
French Title of Invention:
FORMES POSOLOGIQUES À LIBÉRATION PROLONGÉE POUR INHIBITEURS DE TYK2
German Title of Invention:
DOSIERUNGSFORMEN MIT VERLÄNGERTER FREISETZUNG FÜR TYK2-INHIBITOREN
SPC Number:

Dates

Filing date:
18/09/2020
Grant date:
18/02/2026
EP Publication Date:
27/07/2022
PCT Publication Date:
25/03/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/02/2026
EP B1 Publication Date:
18/02/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/09/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/02/2026
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:
BADAWY, Sherif Ibrahim Farag
Address:
United States (US)

2

Name:
YIN, Xiaotian, S.
Address:
United States (US)

3

Name:
BLOOM, Corey
Address:
United States (US)

4

Name:
KESTUR, Umesh
Address:
United States (US)

5

Name:
GRAY, Vivienne
Address:
United Kingdom (GB)

6

Name:
BROWN, Jonathan R.
Address:
United Kingdom (GB)

7

Name:
YATES, Ian
Address:
United States (US)

8

Name:
ZORDAN, Christopher A.
Address:
United States (US)

9

Name:
JONES, John Wynne
Address:
United Kingdom (GB)

10

Name:
CHOI, Candice Y.
Address:
United States (US)

11

Name:
GESENBERG, Christoph
Address:
United States (US)

12

Name:
VIG, Balvinder S.
Address:
United States (US)

Priority

Priority Number:
201962902218 P
Priority Date:
18/09/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/14; A61K 9/16; A61K 47/02; A61K 47/12; A61K 47/26; A61K 47/38; A61K 31/501; A61P 29/00; A61P 37/06;

Publication

European Patent Bulletin

Issue number:
202608
Publication date:
18/02/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
7
Annual Fee Amount:
82 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages